Side-by-side comparison of AI visibility scores, market position, and capabilities
Outpatient addiction and mental health treatment platform, Boston MA, raised $50M+. Value-based care model integrating SUD treatment with mental health support.
Eleanor Health is a Boston, Massachusetts-based behavioral health company founded in 2019 that provides value-based outpatient treatment for substance use disorder (SUD) combined with mental health care. The company has raised over $50 million and operates in multiple states through a hybrid model that combines telehealth with community-based care hubs staffed by multidisciplinary care teams. Eleanor Health treats addiction to opioids, alcohol, and other substances alongside co-occurring mental health conditions such as depression, anxiety, and PTSD.\n\nEleanor Health's care model is built around value-based contracts with Medicaid managed care organizations and commercial health plans, aligning the company's financial incentives with patient outcomes rather than visit volume. Care teams include addiction medicine specialists, therapists, care coordinators, and community health workers who support patients through recovery with a whole-person approach. The platform integrates medication-assisted treatment (MAT), individual and group therapy, and social needs navigation into a coordinated care program.\n\nThe company focuses on serving Medicaid populations with high rates of co-occurring substance use and mental health conditions, a population that historically experiences fragmented care across separate addiction and mental health service systems. Eleanor Health's integrated model is designed to reduce emergency department utilization, hospitalizations, and crisis episodes among high-need members. The company has partnered with several state Medicaid programs and commercial payers to expand access to its model across the Southeast and other regions.
Raised $900M Series E at $11B valuation (Oct 2025). CEO projects ~$2B in 2026 sales. Launched women's health LLM (Feb 2026). Team USA LA28 Olympic partner.
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E financing at an $11 billion valuation in October 2025, reflecting the doubling of its revenue to $500 million in 2024 and a projected $1.5–2 billion in 2026 sales as it expands global distribution into India, UAE, and Latin America.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.